Sequencing Platform Selection, Cost, Accuracy, and Limitations

  • Selecting an appropriate sequencing platform is a fundamental decision in bioinformatics and molecular biology. Different sequencing technologies vary in read length, accuracy, throughput, cost, sample requirements, sequencing speed, and the types of biological information they can generate. The choice of platform influences the quality of sequencing data, the reliability of downstream analysis, and the overall success of a research project. A technology suitable for large-scale genome sequencing may not be the best option for detecting rare mutations, resolving complex structural variations, analysing full-length RNA transcripts, or identifying microorganisms in an environmental sample.
  • Sequencing platforms can broadly be classified into first-generation sequencing, second-generation or next-generation sequencing (NGS), and third-generation sequencing technologies. Sanger sequencing is a widely used first-generation method based on DNA chain termination. Second-generation platforms, particularly Illumina sequencing and semiconductor-based sequencing, generate large numbers of relatively short reads in parallel. Third-generation platforms, including Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT), sequence individual DNA or RNA molecules and can generate long or ultra-long reads. These categories describe technological development, but the capabilities of individual platforms continue to evolve as sequencing chemistry, instruments, and computational methods improve.
  • Sanger sequencing remains useful for targeted analysis of individual DNA fragments, confirmation of selected genetic variants, plasmid verification, and sequencing of PCR products. It typically produces reads of several hundred bases, often approximately 600–1,000 bases under suitable conditions. Its advantages include established workflows, high-quality sequence data for suitable templates, and relatively straightforward interpretation. However, its throughput is low compared with modern NGS platforms, and the cost per base becomes high when large numbers of samples or extensive genomic regions must be analysed. It is therefore generally unsuitable for routine whole-genome sequencing or large-scale transcriptomic studies.
  • Illumina sequencing is one of the most widely used short-read sequencing technologies. It uses sequencing by synthesis, in which DNA fragments are amplified into clusters on a flow cell and fluorescently labelled nucleotides are detected during successive cycles of DNA synthesis. Many Illumina workflows generate paired-end reads, commonly 2 × 150 bases, although read configurations vary by instrument and chemistry. Illumina platforms provide high throughput, high base-level accuracy, and relatively economical sequencing per base when large quantities of data are required. They are widely used for whole-genome sequencing, whole-exome sequencing, targeted gene panels, RNA sequencing, microbial genomics, and metagenomics.
  • The principal limitation of short-read sequencing is its inability to span many long repetitive or structurally complex genomic regions. Reads may map to multiple locations, making it difficult to distinguish similar genes, duplicated sequences, segmental duplications, and complex rearrangements. Short reads also provide limited long-range information for phasing variants onto parental or chromosome-specific haplotypes. Coverage can be uneven in regions with extreme GC content or difficult sequence composition. These limitations do not make short-read sequencing unsuitable for such regions in every case, but they can reduce the confidence of assembly and variant interpretation.
  • Semiconductor sequencing, commonly associated with Ion Torrent technology, detects changes in hydrogen ion concentration produced during nucleotide incorporation. It can provide relatively rapid sequencing and is used in targeted sequencing, microbial analysis, and selected clinical and research workflows. Its read lengths and throughput depend on the instrument and chip configuration. A characteristic limitation is the difficulty of determining the exact number of identical bases in long homopolymer regions, which can produce insertion and deletion errors. The suitability of semiconductor sequencing therefore depends on the target regions, assay validation, and the required accuracy for the intended application.
  • PacBio sequencing uses single-molecule real-time (SMRT) technology. DNA polymerase incorporates fluorescently labelled nucleotides, and the resulting signals are detected as DNA synthesis occurs. PacBio HiFi sequencing uses circularized DNA templates and repeated observations of the same insert to generate highly accurate consensus reads. HiFi reads commonly span approximately 10–25 kilobases, although read length depends on library preparation and experimental conditions. This combination of long reads and high consensus accuracy makes PacBio particularly useful for de novo genome assembly, structural variant detection, haplotype phasing, repeat analysis, and full-length transcript sequencing.
  • The main limitations of PacBio sequencing include the need for suitable high-quality DNA or RNA, specialized library preparation, and access to dedicated sequencing instruments or service providers. The amount of data generated per run and the cost per sample may be less favourable than short-read sequencing for projects requiring very large quantities of relatively simple sequence data. However, the value of long, accurate reads can outweigh these limitations when the research objective involves complex genomic regions, structural variation, or accurate haplotype reconstruction.
  • Oxford Nanopore sequencing measures changes in ionic current as individual DNA or RNA molecules pass through nanopores. Basecalling algorithms interpret these electrical signals and convert them into nucleotide sequences. Depending on the instrument, chemistry, and library preparation, ONT can generate reads ranging from several kilobases to hundreds of kilobases, with exceptionally long molecules sometimes extending beyond one megabase. Its major strengths include flexible read lengths, real-time data generation, portable sequencing devices, direct sequencing of native DNA and RNA, and the ability to detect certain molecular modifications.
  • Oxford Nanopore sequencing is particularly useful for genome assembly, structural variant analysis, repetitive regions, transcript isoform characterization, microbial sequencing, and field-based genomic investigations. Its limitations include chemistry- and model-dependent error profiles, sensitivity to DNA quality and library preparation, and the need for suitable basecalling and downstream analysis. Although accuracy has improved substantially, performance should be evaluated using the specific chemistry, basecaller, and sequencing configuration intended for the project rather than relying on a single historical error-rate estimate.
  • The choice between short-read and long-read sequencing depends on the biological question. Short reads are often advantageous when large numbers of samples must be analysed economically, when high base-level accuracy is important, or when the main objective is to identify common single-nucleotide variants and quantify gene expression. Long reads are particularly valuable when the analysis requires resolving repetitive regions, detecting large structural variants, reconstructing complete transcripts, phasing haplotypes, or producing more contiguous genome assemblies. In some projects, combining short-read and long-read sequencing provides a more complete solution than relying on either technology alone.
  • A simplified comparison of major sequencing technologies is presented below. The ranges are illustrative rather than fixed specifications because performance varies among instruments, chemistry versions, library preparation protocols, sequencing runs, and analysis methods.
Platform or technologyTypical read lengthMain strengthsImportant limitations
Sanger sequencingApproximately 600–1,000 bpTargeted sequencing, familiar workflow, high-quality readsLow throughput and high cost per base
Illumina sequencingCommonly 2 × 150 bp; other configurations availableHigh throughput, high base-level accuracy, economical large-scale sequencingShort reads, limited phasing, difficulty with long repeats
Semiconductor sequencingOften hundreds of bases, depending on systemRapid targeted sequencing and selected applicationsHomopolymer-associated indel errors and platform-specific throughput
PacBio HiFiCommonly approximately 10–25 kbLong reads with high consensus accuracy, phasing, assembly, structural variantsSpecialized instruments and library requirements; cost depends on project scale
Oxford NanoporeCommonly several to tens of kilobases; ultra-long reads possibleFlexible read lengths, real-time analysis, portable devices, native DNA/RNA sequencingChemistry- and basecaller-dependent errors; DNA quality and handling are important
  • Sequencing accuracy is one of the most important criteria in platform selection. It describes how closely the reported nucleotide sequence corresponds to the original biological molecule. Accuracy can be measured at different levels, including raw read accuracy, consensus accuracy, mapped-read accuracy, and final variant-call accuracy. These measurements are not interchangeable. A platform may have a relatively high raw-read error rate but produce highly accurate consensus sequences when multiple observations are combined. Conversely, high average read accuracy does not guarantee correct variant calls in difficult genomic regions.
  • Raw-read accuracy describes the correctness of an individual sequencing read before consensus generation or other error-correction procedures. Consensus accuracy describes the accuracy of a sequence obtained by combining multiple observations of the same molecule or genomic region. PacBio HiFi reads, for example, use repeated observations of circular DNA templates to produce consensus sequences. Nanopore workflows can also use duplex sequencing, in which information from both strands of a DNA molecule is combined, or computational consensus approaches to improve accuracy. Illumina short reads generally provide high per-base accuracy directly, although sequencing errors and systematic biases remain possible.
  • Sequencing errors may involve substitutions, insertions, or deletions. Substitution errors occur when one nucleotide is incorrectly identified as another. Insertion errors occur when additional bases are reported, while deletion errors occur when bases are omitted. Different technologies have different error profiles. Short-read sequencing commonly produces substitution errors, while some long-read workflows have historically been more affected by insertions and deletions. Homopolymer regions, repetitive sequences, modified bases, and low-complexity regions can create challenges for several technologies. The exact error profile depends on the chemistry, instrument, basecalling software, and experimental conditions.
  • Phred quality scores provide a standard way of expressing the estimated probability that a base call is incorrect. A higher score indicates a lower estimated error probability. For example, Q20 corresponds to an estimated error probability of 1%, while Q30 corresponds to 0.1%. These scores are useful for evaluating sequencing data, but they should not be interpreted as a complete measure of biological accuracy. Mapping errors, contamination, sample mixtures, PCR artifacts, and systematic biases may remain even when individual base quality scores are high.
  • The accuracy required for a sequencing project depends on the intended application. For common germline variant detection, high-quality reads and adequate coverage are needed to distinguish genuine variants from sequencing errors. For rare-variant detection, the required evidence is more demanding because the alternative allele may be represented by only a small proportion of reads. In cancer sequencing, low-frequency somatic mutations may require high effective depth, error suppression, and validated analytical procedures. In genome assembly, both read accuracy and read length influence the ability to reconstruct correct genomic sequences. For transcriptomics, accurate mapping and appropriate library design are important for reliable expression estimates and transcript identification.
  • Sequencing cost is another major factor in platform selection. The total cost of a sequencing project includes more than the price of generating sequence data. It may include instrument acquisition or access fees, flow cells or sequencing chips, reagents, library preparation kits, nucleic acid extraction, sample quality assessment, personnel, data storage, computational resources, data analysis, and validation experiments. When sequencing is performed by an external provider, the quoted price may include some of these services but exclude others. A meaningful cost comparison should therefore consider the complete experimental and computational workflow.
  • Cost per base or cost per gigabase is commonly used to compare sequencing technologies. It represents the approximate expense of generating a given quantity of sequence data. However, this metric does not capture the biological usefulness of the reads. For example, a short-read platform may generate many gigabases at a relatively low cost, but those reads may not resolve a large structural variant or a complex repetitive region. A long-read platform may generate fewer bases at a higher cost per gigabase, yet provide the long-range information required to answer the research question. The most economical technology is therefore not necessarily the one with the lowest cost per base.
  • Instrument costs also vary considerably. Large high-throughput sequencing systems generally require substantial initial investment, laboratory infrastructure, maintenance, and trained personnel. Smaller benchtop or portable instruments may have lower entry costs and can be suitable for laboratories with limited sequencing requirements. However, the cost of consumables, flow cells, reagents, service contracts, and data processing must still be considered. Outsourcing sequencing to a service provider can reduce the need for instrument ownership, although sample shipping, service charges, turnaround time, and data delivery arrangements may affect the total project cost.
  • Sequencing throughput is closely related to cost efficiency. High-throughput instruments can generate large amounts of data in a single run, making them suitable for large population studies, genome projects, and large-scale transcriptomics. However, a high-capacity instrument may be inefficient for a small project if the sequencing capacity cannot be filled appropriately. Smaller instruments or external sequencing services may be more economical for limited sample numbers. The number of samples, required sequencing depth, read length, and expected data volume should be estimated before selecting an instrument.
  • Library preparation costs also influence platform selection. Different technologies require specific library preparation kits, adapters, barcodes, and sample input quantities. Long-read workflows may require high-molecular-weight DNA and careful sample handling, while some short-read protocols can work with lower DNA input quantities. Targeted sequencing may require capture probes or custom amplification primers, adding to the cost. RNA sequencing may require poly(A) selection, ribosomal RNA depletion, reverse transcription, or specialized library preparation for small RNA and single-cell analysis. These expenses should be included when estimating the cost per sample.
  • The cost of bioinformatics analysis is another important consideration. Short-read sequencing datasets often require substantial computational resources when millions or billions of reads are generated across many samples. Long-read data may require more demanding basecalling, assembly, polishing, phasing, or structural variant analysis, depending on the workflow. Storage requirements can be substantial, particularly when raw signal data, intermediate files, and multiple versions of processed datasets are retained. Cloud computing, high-performance computing clusters, workflow management systems, and data backup arrangements can all contribute to project costs.
  • Platform selection should begin with a clear definition of the research objective. If the main goal is to identify single-nucleotide variants across many samples, a high-accuracy short-read platform may be an appropriate choice. If the objective is to resolve complex structural variants, repetitive regions, or haplotypes, long-read sequencing may provide important advantages. If the project requires rapid sequencing in a field setting or real-time monitoring, a portable nanopore instrument may be particularly useful. If only a specific DNA fragment or a small number of known regions must be examined, Sanger sequencing or targeted sequencing may be more economical than whole-genome sequencing.
  • For whole-genome sequencing, Illumina is often suitable for large-scale short-read studies, while PacBio HiFi and Oxford Nanopore can provide additional information for complex genome assembly and structural variation. Hybrid sequencing combines short and long reads to take advantage of their complementary properties. Short reads can help improve base-level accuracy or provide additional evidence, while long reads can bridge repetitive regions and support more contiguous assemblies. The usefulness of hybrid sequencing depends on the genome, project objectives, and availability of appropriate analysis methods.
  • For whole-exome sequencing, short-read sequencing is widely used because the main objective is to analyse protein-coding regions and selected nearby sequences. Capture-based enrichment allows sequencing capacity to be concentrated on targeted genomic regions. The main limitations include uneven capture efficiency, incomplete coverage of some exons, and limited detection of certain structural or noncoding variants. Long-read targeted sequencing may be useful for selected genes or regions that are difficult to analyse using short reads, particularly when phasing or complex rearrangements are important.
  • For targeted gene panels, the choice depends on the number of genes, expected variant types, required sensitivity, and sample characteristics. Short-read platforms can provide high depth over a defined set of genes and are widely used for inherited disease and cancer panels. Long-read targeted approaches may be valuable for complex loci, repeat expansions, structural variants, or allele phasing. Sanger sequencing may be used to confirm selected findings, although confirmation requirements depend on assay validation, laboratory procedures, and the clinical or research context.
  • For RNA sequencing, Illumina is commonly used for gene expression profiling and differential expression analysis. Its high throughput supports the analysis of many samples and biological replicates. PacBio Iso-Seq and Oxford Nanopore sequencing can provide full-length transcript information, helping researchers characterize alternative splicing, transcript isoforms, and complex gene structures. Short-read and long-read RNA sequencing can also be combined when both accurate expression quantification and full-length transcript characterization are required.
  • For metagenomics, platform selection depends on whether the objective is taxonomic profiling, microbial genome reconstruction, functional analysis, or rapid pathogen detection. Short-read shotgun metagenomics can provide large quantities of sequence data suitable for taxonomic and functional profiling. Long reads can improve microbial genome assembly and help connect genes, plasmids, and mobile genetic elements. Targeted amplicon sequencing, such as 16S rRNA gene sequencing, may be sufficient when the research question focuses on selected microbial marker genes rather than the complete genetic content of a community.
  • For single-cell sequencing, the platform choice is determined not only by the sequencing instrument but also by the cell capture and library preparation technology. Short-read sequencing is widely used for single-cell RNA sequencing because cell barcodes and unique molecular identifiers can be processed efficiently at high throughput. Long-read sequencing can provide additional information about full-length transcript isoforms, although the experimental design and sequencing depth per cell require careful consideration. Single-cell DNA sequencing and single-cell epigenomic assays also have distinct technical requirements.
  • For clinical and diagnostic applications, platform selection must consider analytical validation, sensitivity, specificity, reproducibility, sample type, turnaround time, and regulatory requirements. A sequencing technology should not be selected solely because it has the longest reads or the highest advertised accuracy. The complete assay must be validated for the intended variant classes and genomic regions. Laboratories should establish performance characteristics such as the limit of detection, minimum coverage, false-positive rate, false-negative rate, and reproducibility. Clinical interpretation also requires suitable reference databases, evidence standards, and confirmatory procedures where appropriate.
  • Sequencing limitations are not restricted to the technology itself. Sample quality, DNA extraction, RNA degradation, library preparation, amplification bias, contamination, sequencing depth, mapping algorithms, reference genome quality, and bioinformatics parameters can all influence the final results. A sequencing platform with excellent technical performance may still produce unreliable biological conclusions if the sample is contaminated, the experimental design is inadequate, or the analysis is inappropriate. Platform performance should therefore be evaluated as part of the entire sequencing workflow.
  • Another important limitation is that different sequencing platforms may produce results that are not directly interchangeable. Differences in read length, error profiles, library preparation, coverage distribution, and basecalling algorithms can affect variant detection and gene expression measurements. When datasets from different technologies are combined, researchers should evaluate potential batch effects and technical differences. Appropriate normalization, benchmarking, reference materials, and platform-specific quality control may be necessary before making biological comparisons.
  • Benchmarking is essential for understanding the real performance of sequencing platforms. Reference samples with well-characterized genomes can be used to evaluate read accuracy, mapping performance, coverage uniformity, variant detection, and reproducibility. Public benchmark resources and standardized reference materials help researchers compare analytical workflows. However, benchmarking results must be interpreted in the context of the tested sample, sequencing chemistry, software versions, and genomic regions. No single benchmark provides a universal ranking of all sequencing platforms for every biological application.
  • A practical platform selection process should consider the following factors together: the biological question, target molecule, required read length, expected variant types, desired accuracy, sequencing depth, number of samples, throughput, sample quality, available budget, turnaround time, laboratory infrastructure, and computational capacity. Researchers should also consider whether the project requires raw reads, consensus sequences, genome assemblies, variant calls, expression matrices, or other processed outputs. The required output determines which sequencing and analysis methods are appropriate.
  • For reproducible research, the selected platform and its configuration should be documented carefully. Important details include the instrument model, sequencing chemistry, flow cell or chip type, read configuration, library preparation kit, sequencing depth, basecalling software and version, quality-control procedures, alignment software, variant-calling methods, and reference genome version. Cost estimates should specify whether they include library preparation, sequencing reagents, instrument access, data storage, computational analysis, and validation. Researchers should avoid comparing platform prices without checking that the quoted services provide equivalent quantities and types of usable data.
  • No single sequencing platform is universally superior. Illumina offers high-throughput, accurate short reads and is widely used for large-scale genomic and transcriptomic studies. PacBio HiFi provides long reads with high consensus accuracy, making it valuable for genome assembly, variant detection, and haplotype analysis. Oxford Nanopore offers flexible read lengths, real-time sequencing, and portable instruments, with particular advantages for ultra-long reads and direct molecule analysis. Sanger sequencing remains useful for targeted applications, while semiconductor sequencing supports selected rapid and targeted workflows. The most appropriate platform is the one that provides the necessary biological information at an acceptable level of accuracy, cost, and operational complexity.
  • Sequencing platform selection is therefore a balance between scientific objectives, technical performance, financial resources, and analytical requirements. A careful evaluation of read length, accuracy, throughput, cost, sample requirements, and limitations helps researchers design efficient experiments and avoid unnecessary sequencing expenses. Understanding these trade-offs is essential for producing reliable, reproducible, and biologically meaningful results in modern bioinformatics.

Author:

Leave a Reply

Your email address will not be published. Required fields are marked *